HLA-B*15:02 testing are available in Bangkok through support from NHSO

Beginning from 1st October 2013, HLA-B*15:02 is accessible to majority of Thai citizen who is attending 53 hospitals in Bangkok supported by National Health Security Office (NHSO). The tests are available for the first 2,000 patients who initiated Carbamazepine and this is the preventive measure fot reducing the SJS/TENS in Bangkok.

Link to flyer for HLA-B*15:02 pilot test

posted Mar 31, 2014, 9:47 AM by Surakameth Mahasirimongkol

HLA-B*15:02 tests are pilot testing in Bangkok

posted Aug 10, 2013, 1:29 PM by Surakameth Mahasirimongkol   [ updated Sep 4, 2013, 8:03 PM ]

Start from 1st October HLA-B*15:02 test are supported for all patients in Bangkok,
Please contact dmscnetwork@thailandpg.org for more information

14th June 2012; The progress monitoring meeting of ThaiSCAR

posted Jun 17, 2012, 2:47 AM by Surakameth Mahasirimongkol   [ updated Jun 18, 2012, 5:40 AM ]

Hospitals in the network
On 14th June 2012, we have an annual gathering of pharmacists and doctors who were participated and contributed to the establishment of the TPGN. Current number of hospitals participated is 18 and this number is keep growing, thanks to the help from our friends in Thai FDA.

In the meeting, we reported the results of analysis of first 29 cases of SJS/TENS enrolled from 5 hospitals in the first year of the study, the results were of most interested to the participants and we're looking forward for a detail analysis after we're getting more samples at the end of Thai fiscal year in September. 

We would like to also welcome new participants from the new members of the networks. Current members included 16 hospitals distributed all over Thailand, and the number is keep growing. This number will be updated annually in our website.


19th May 2011 meeting for ThaiSCAR study

posted May 16, 2011, 11:55 AM by Surakameth Mahasirimongkol   [ updated May 26, 2011, 1:11 AM by DMSc Network ]

1st investigator meeting for pharmacogenomics study of severe cutaneous adverse reactions in Thailand. This is collaborative study between Thais FDA and DMSc for collection of samples and analysis of genetic association study.

The meeting went very well, thanks to very active collaborators from many provinces.

From

August meeting for utilization of pharmacogenomics in Thailand

posted May 4, 2010, 2:09 PM by Surakameth Mahasirimongkol   [ updated Jul 4, 2010, 10:28 AM ]

A meeting will be held on 26th august 2010 for the discussion to implement the HLA-B tests for medical services providers in Thailand. A expert panel will be called from neurologists in Ministry of public health to discuss the utility of HLA-B*1502 to prevent Carbamazepine induced SJS/TENS in Thais. If the panels agrees in pursing the further research and/or services, we will form a formal collaboration among the participants and establish a formal conversation for utilization of pharmacogenomics in Thailand.

The meeting venue will be at Miracle Grand Hotel, coincides with DMSc research meeting 

Confirmed Speakers.

GAP-J 2010 meeting in Hawai'i

posted Feb 15, 2010, 3:05 PM by Surakameth Mahasirimongkol

During 9-10 February 2010, Dr. Surakameth Mahasirimongkol was invited to attend the Global Alliance for Pharmacogenomics (GAP-J) meeting.
The alliance shall expand this year to include France and Thailand as two new alliances. The meeting is very interesting for pharmacogenomics research.
Various pharmacogenomics researches were presented at the meeting with results of genome-wide association analysis shown for various drugs/diseases.
We are looking for new fruitful collaboration with our global colleagues.

Queen Sirikit National Institute of Child Health

posted Aug 11, 2009, 6:41 AM by Surakameth Mahasirimongkol   [ updated Aug 11, 2009, 5:37 PM ]

The meeting with Clinical Neurologist and Dermatologists in the Queen Sirikit National Institute of Child Health on 11/8/2009 was concluded that the following three activities shall be set up for the pharmacogenomics research collaboration between DMSc and the QSNICH.

1) Case-control study for association analysis of HLA-B*1502 in Thai Children who prescribed Carbamazepine.
2) Participating in the multi-center clinical research network for clinical investigation of SJS/TENS in Thailand.
3) Operational study for Prospective intervention using HLA-B*1502 status to prevent Carbamazepine induced SJS/TENS.

Meeting with NHSO director

posted Aug 10, 2009, 12:35 AM by Surakameth Mahasirimongkol

10/8/2009 A meeting with NHSO director to explore the possibility of PG test in Thailand

1-8 of 8